BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

1937

524518

KREBSBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KREBS BIOCHEMICALS & IND performance

Today’s low

Today’s high

₹ 69.11 ₹ 73.00
₹ 70.39

52 week low

52 week high

₹ 65.55 ₹ 129.07
₹ 70.39

Open Price

₹ 73.00

Prev. Close

₹ 69.04

Volume (Shares)

770.00

Total traded value

₹ .54

Upper Circuit

₹ 75.94

Lower Circuit

₹ 62.13

info

KREBS BIOCHEMICALS & IND Share Price Update

As of the latest trading session, KREBS BIOCHEMICALS & IND share price is currently at ₹ 70.37, which is up by ₹ 1.33 from its previous closing. Today, the stock has fluctuated between ₹ 69.11 and ₹ 73.00. Over the past year, KREBS BIOCHEMICALS & IND has achieved a return of -15.71 %. In the last month alone, the return has been -2.25 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KREBS BIOCHEMICALS & IND fundamentals


  • Market cap (Cr)

    151.30

  • P/E Ratio (TTM)

    -5.53

  • Beta

    1.43

  • Book Value / share

    -67.82

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -5.32

info icon alternate text
  • Market cap (Cr)

    149.80

  • P/E Ratio (TTM)

    -5.53

  • Beta

    1.25

  • Book Value / share

    -67.82

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -5.32

info icon alternate text

KREBS BIOCHEMICALS & IND Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 5.48
Operating Expense 10.82
Net Profit -5.32
Net Profit Margin (%) -97.08
Earnings Per Share (EPS) -2.47
EBITDA -2.07
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 6.10
Operating Expense 14.69
Net Profit -8.27
Net Profit Margin (%) -135.57
Earnings Per Share (EPS) -3.83
EBITDA -5.06
Effective Tax Rate (%) -0.24
Particulars DEC 2024 (Values in Cr)
Revenue 11.47
Operating Expense 19.45
Net Profit -7.74
Net Profit Margin (%) -67.48
Earnings Per Share (EPS) -3.59
EBITDA -4.46
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 12.86
Operating Expense 18.70
Net Profit -5.76
Net Profit Margin (%) -44.79
Earnings Per Share (EPS) -2.67
EBITDA -2.63
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 12.89
Operating Expense 18.10
Net Profit -5.17
Net Profit Margin (%) -40.10
Earnings Per Share (EPS) -2.40
EBITDA -2.15
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 43.31
Operating Expense 70.94
Net Profit -26.94
Net Profit Margin (%) -62.20
Earnings Per Share (EPS) -12.49
EBITDA -14.32
Effective Tax Rate (%) -0.07
Particulars MAR 2024 (Values in Cr)
Revenue 50.42
Operating Expense 70.60
Net Profit -19.73
Net Profit Margin (%) -39.13
Earnings Per Share (EPS) -9.16
EBITDA -8.27
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 52.13
Operating Expense 77.44
Net Profit -24.69
Net Profit Margin (%) -47.36
Earnings Per Share (EPS) -11.30
EBITDA -15.16
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 59.70
Operating Expense 105.38
Net Profit -44.53
Net Profit Margin (%) -74.58
Earnings Per Share (EPS) -20.81
EBITDA -32.84
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 38.61
Operating Expense 82.68
Net Profit -28.36
Net Profit Margin (%) -73.45
Earnings Per Share (EPS) -14.37
EBITDA -16.95
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -67.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -33.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share -55.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.83
EBITDA Margin -16.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share -46.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.78
EBITDA Margin -29.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share -34.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.23
EBITDA Margin -55.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share -23.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -31.56
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 169.03
Total Liabilities 169.03
Total Equity -146.23
Share Outstanding 21560000
Price to Book Ratio -0.98
Return on Assets (%) -15.93
Return on Capital (%) -40.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 178.17
Total Liabilities 178.17
Total Equity -119.21
Share Outstanding 21560586
Price to Book Ratio -1.10
Return on Assets (%) -11.07
Return on Capital (%) -26.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 174.98
Total Liabilities 174.98
Total Equity -99.46
Share Outstanding 21560000
Price to Book Ratio -1.22
Return on Assets (%) -14.11
Return on Capital (%) -29.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 189.80
Total Liabilities 189.80
Total Equity -75.09
Share Outstanding 21560000
Price to Book Ratio -4.12
Return on Assets (%) -23.45
Return on Capital (%) -65.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 159.22
Total Liabilities 159.22
Total Equity -42.73
Share Outstanding 19620000
Price to Book Ratio -3.72
Return on Assets (%) -17.81
Return on Capital (%) -41.82
Particulars MAR 2025 (Values in Cr)
Net Income -26.92
Cash from Operations -7.87
Cash from Investing -4.96
Cash from Financing 12.86
Net change in Cash 0.00
Free Cash Flow -4.47
Particulars MAR 2024 (Values in Cr)
Net Income -19.72
Cash from Operations 2.36
Cash from Investing -7.81
Cash from Financing 5.50
Net change in Cash 0.05
Free Cash Flow 11.77
Particulars MAR 2023 (Values in Cr)
Net Income -24.69
Cash from Operations -24.71
Cash from Investing -12.64
Cash from Financing 37.34
Net change in Cash -0.01
Free Cash Flow -9.55
Particulars MAR 2022 (Values in Cr)
Net Income -44.52
Cash from Operations -17.21
Cash from Investing -22.89
Cash from Financing 39.50
Net change in Cash -0.61
Free Cash Flow 9.86
Particulars MAR 2021 (Values in Cr)
Net Income -28.35
Cash from Operations -14.57
Cash from Investing -22.54
Cash from Financing 37.66
Net change in Cash 0.53
Free Cash Flow 3.18
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 13.29 1.78 249.44 30.00 / 68.00
BLISS GVS PHARMA LTD 156.60 15.52 1.57 1654.47 105.05 / 190.65
CIPLA LTD 1501.65 22.29 3.68 121298.96 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 275.65 7.76 2.23 811.27 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2624.25 46.95 22.78 44456.38 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 17.69 5.14 249.44 30.00 / 68.00
AMRUTAJAN HEALTH LTD 724.70 38.43 6.41 2095.15 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9535.45 112.73 30.94 23838.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 156.60 23.44 1.56 1654.47 105.05 / 190.65

KREBS BIOCHEMICALS & IND shareholding pattern

Holding

Others
26.75%
Promoter Holdings
72.74%
FII
0.49%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ipca Laboratories Limited 1.0705195E7 (49.65%) Shareholding of Promoter and Promoter Group
Hemalatha Ravi 2691524.0 (12.48%) Shareholding of Promoter and Promoter Group
Avinash Ravi 2140272.0 (9.93%) Shareholding of Promoter and Promoter Group
Sun Pharmaceutical Industries Ltd 1036943.0 (4.81%) Public Shareholding
Ajay Ravi 112997.0 (0.52%) Shareholding of Promoter and Promoter Group
Dr R T Ravi 23474.0 (0.11%) Shareholding of Promoter and Promoter Group
Aditya Ravi 10672.0 (0.05%) Shareholding of Promoter and Promoter Group
Natwest Markets Plc 522.0 (0.0%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

KREBS BIOCHEMICALS & IND Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
70.19 1.66 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 69.70
  • 26 Days 71.20
  • 10 Days 70.00
  • 50 Days 73.00
  • 12 Days 70.10
  • 100 Days 75.70
  • 20 Days 70.70
  • 200 Days 78.60
70.18 PIVOT

First Support

68.98

First Resistance

70.86

Second Support

68.30

Second Resistance

72.06

Third Support

67.10

Third Resistance

72.74

RSI

41.81

ADX

25.56

MACD

-1.09

Williams % R

-55.48

Commodity Channel Index (CCI)

-103.19

Date

2025-10-31

Week

5678.00

Same Day

14428.00

Month

5465.00

1 Year

1.43

3 Year

1.02

Over 1 Month

-2.25%

down

Over 1 Year

-15.71%

down

Over 3 Months

-11.92%

down

Over 3 Years

-16.52%

down

Over 6 Months

-6.84%

down

Over 5 Years

-4.50%

down

KREBS BIOCHEMICALS & IND Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

KREBS BIOCHEMICALS & IND Share Price

Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.

Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.

KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994.

During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

The Company commissioned 2.5 MW Co-generation Power Plant at Unit II in Vizag during 2003-04 and started operations on it from July, 2004 onwards.

Parent organization Indian Private
NSE symbol KREBSBIO
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of [-]?

Answer Field

[-] share price is for NSE ₹ [-] & for BSE ₹ [-] as on Nov 03 2025 10:34 AM.

What is the Market Cap of [-] Share?

Answer Field

The market cap of [-] for NSE ₹ [-] & for BSE ₹ [-] as on Nov 03 2025 10:34 AM.

What is the 52 Week High and Low of [-]?

Answer Field

The 52 Week High and Low of [-] for NSE is ₹ [-] and ₹ [-] and for BSE is ₹ [-] and ₹ [-].

What is 1 year return for [-]?

Answer Field

The 1 year returns on the stock has been [-]%.

What is the P/E Ratio of [-] Share?

Answer Field

As on Nov 03 2025 10:34 AM the price-to-earnings (PE) ratio for [-] share is -5.53.

What is the PB ratio of [-] Share?

Answer Field

As on Nov 03 2025 10:34 AM, the price-to-book (PB) ratio for [-] share is -67.82.

How to Buy [-] Share on Bajaj Broking App?

Answer Field

To buy [-] shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “[-]”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59